Boot sales boosted by new private-label Viagra rival

0

Boots is seeing a surge in sales thanks to its new Viagra-rivaling erectile dysfunction treatment.

The drugstore and beauty chain said sales of its retail healthcare arm, which includes over-the-counter drugs and treatments, rose nearly 14% in the three months to the end of August.

Boots specifically called out the buoyant sales of its Sildenafil, a Viagra alternative, which it began selling in early June.

The treatment is Boots’ first own-brand erectile dysfunction treatment and is sold without a prescription, although customers must consult a Boots pharmacist before they can purchase. Boots also sells Viagra.

Sildenafil is part of a larger effort by Boots to provide own-brand alternatives to branded products. Nearly one in two health products sold at Boots is now its own brand.

Boots said pharmacy sales had fallen as Covid-induced demand waned.

However, in-store transactions rose by more than a fifth in the three months to the end of August, compared to the same period a year earlier. Its travel stores were particularly busy, as the holidays resumed and people began to visit offices again. Sales of deodorants are up 46% from a year ago, which he attributes to the return of workers to inner cities.

Sales of sunscreen, meanwhile, have increased by 150%, thanks in part to foreign breaks but also to the recent heat wave. Boots recently said it was stopping making all Soltan sunscreen below factor 15 in a bid to reduce customers’ risk of developing skin cancer.

Strong health care sales helped Boots’ total retail sales surpass pre-pandemic levels.

Chef Sebastian James called it an “encouraging” set of results.

The latest figures came as parent company Walgreens Boots Alliance posted better than expected results. Earlier this year, Walgreens scrapped plans to sell Boots amid market turmoil.

Signs of high demand for Boots’ erectile dysfunction treatment come after recent research suggested erectile dysfunction could be linked to long Covid.

Researchers from the University of Birmingham said this summer it was among a number of new symptoms that had been identified, which also included hair loss.

Share.

Comments are closed.